E L Golovina

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Health Information

Randomized Controlled Trial

Dna Methylation

Cardiovascular Risk Factors

Top Venues

Terapevticheskii arkhiv

This page only lists publications with an associated author ORCID identifier.

Publications

E L Golovina, Olga Evgenevna Vaizova, M V Meleshko, Iuliia G Samoilova, D V Podchinenova, Anastasia Borozinets, Mariia V Matveeva, Dmitry Anatolievich Kudlay
[Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review]. Terapevticheskii arkhiv 95 (8) (2023)
E L Golovina, I R Grishkevich, Olga Evgenevna Vaizova, Iuliia G Samoilova, D V Podchinenova, Mariia V Matveeva, Dmitry Anatolievich Kudlay
[Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review]. Terapevticheskii arkhiv 95 (3) (2023)
E L Golovina, I R Grishkevich, Olga Evgenevna Vaizova, Iuliia G Samoilova, D V Podchinenova, Mariia V Matveeva, Dmitry Anatolievich Kudlay
[Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review]. Terapevticheskii arkhiv 95 (3) (2023)
E L Golovina, Olga Evgenevna Vaizova, M V Meleshko, Iuliia G Samoilova, D V Podchinenova, Anastasia Borozinets, Mariia V Matveeva, Dmitry Anatolievich Kudlay
[Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review]. Terapevticheskii arkhiv 95 (8) (2023)
E L Golovina, I R Grishkevich, Olga Evgenevna Vaizova, Iuliia G Samoilova, D V Podchinenova, Mariia V Matveeva, Dmitry Anatolievich Kudlay
[Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review]. Terapevticheskii arkhiv 95 (3) (2023)